Cough, Thyroid Neoplasm
Conditions
Brief summary
This study is a randomized controlled trial. Adult patients undergoing thyroidectomy under general anesthesia at Severance Hospital and Yonsei Cancer Center are included in tis study. For intervention group, patients receive anesthesia with total intravenous remimazolam, while for control group, patients receive anesthesia with inhalation anesthetic. The primary end point of the study is to determine whether coughing during endotracheal tube extubation is less when anesthesia is maintained with intravenous remimazolam compared to inhalation anesthetics. The secondary end points are cough score (graded into 4 levels), frequency of reoperation due to postoperative bleeding, These include the frequency of hypertension during the extubation process and whether additional painkillers are used in the recovery room.
Interventions
DRUGTotal intravenous anesthesia with Byfavo
General anesthesia is maintained with intravenous continuous administration of Byfavo.
DRUGInhalation anesthesia with Sevoflurane
General anesthesia is maintained with Sevoflurane.
Sponsors
Yonsei University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Intervention model description
a single-blinded randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Adult patients aged 19 years or older undergoing thyroidectomy under general anesthesia at Severance Hospital Cancer Center.
Exclusion criteria
* Patients with American society of anesthesiologists physical status classification IV or higher. * Patients who are hypersensitive to remimazolam or inhalational anesthetic. * Patients with structural abnormalities in the upper airway or respiratory diseases. * Patients with a history of upper respiratory tract infection within the past 2 weeks. * Current smoker * Pregnant * Patients who have difficulty reading and understanding the informed consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of patients not coughing during postoperative extubation | Until discharge (3days on average) | Proportion of patients not coughing during postoperative extubation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cough score | Until discharge (3days on average) | Cough score (4 scale score: 1- no cough, 2: cough once, 3: cough lating less than 5 seconds, 4: cough lating longer than 5 seconds.) |
Countries
South Korea
Outcome results
None listed